ConductScience.org, home

Paper82837

Cyclosporin A for the treatment of graft-versus-host disease in man.

Powles RL and 5 others. Lancet, 1978. Cited by 240 papers, by iCite.

Cite this record

ConductScience Library. Cyclosporin A for the treatment of graft-versus-host disease in man. Papers, record 82837. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/82837

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclosporin A for the treatment of graft-versus-host disease in man.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
240
iCite
Relative citation ratio, by iCite
9.84
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Powles RLR L
2Barrett AJA J
3Clink HH
4Kay HEH E
5Sloane JJ
6McElwain TJT J

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bone Marrow TransplantationMajor topic
Fungal ProteinsMajor topic
Graft vs Host ReactionMajor topic
Immunosuppressive AgentsMajor topic
Peptides, CyclicMajor topic
Postoperative ComplicationsMajor topic
Administration, Oral
Adolescent
Adult
Drug Evaluation
Female
Hepatic Encephalopathy
Humans
Injections, Intramuscular
Leukemia, Monocytic, Acute
Leukemia, Myeloid, Acute
Liver Function Tests
Male
Peptides
Transplantation, Isogeneic

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 240 citations.

PMIDTitleJournalYearIn PapersSource
39231914Therapeutic efficacy of rituximab combined with cyclosporin A on B-cell dysregulation in chronic graft-versus-host disease.Clin Transl Oncol2025https://conductscience.org/library/papers/39231914PubMed
32786098Calcineurin inhibitor (CNI)-associated skin cancers: New insights on exploring mechanisms by which CNIs downregulate DNA repair machinery.Photodermatol Photoimmunol Photomed2020https://conductscience.org/library/papers/32786098PubMed
32437331Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.J Clin Invest2020https://conductscience.org/library/papers/32437331PubMed
23278640Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Leuk Lymphoma2013https://conductscience.org/library/papers/23278640PubMed
19857584Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease?Biol Blood Marrow Transplant2010https://conductscience.org/library/papers/19857584PubMed
16068182Selective effects of cyclosporin A on colony-forming lymphoid and myeloid cells in man.Nature1979https://conductscience.org/library/papers/16068182PubMed
10833252Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles.World J Surg2000https://conductscience.org/library/papers/10833252PubMed
8575558The history of cyclosporin A (Sandimmune) revisited: another point of view.Experientia1996https://conductscience.org/library/papers/8575558PubMed
7459257Hepatic and renal function in rats receiving immunotherapeutic doses of cyclosporin A.Br J Exp Pathol1980https://conductscience.org/library/papers/7459257PubMed
7042484Liver disease after bone marrow transplantation.Gut1982https://conductscience.org/library/papers/7042484PubMed
7041349Cyclosporin A hepatotoxicity in 66 renal allograft recipients.Transplantation1981https://conductscience.org/library/papers/7041349PubMed
703176099mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.Radiology1982https://conductscience.org/library/papers/7031760PubMed
7015660Cyclosporin A in clinical organ grafting. First Northern Ireland Kidney Research Fund lecture.Ulster Med J1981https://conductscience.org/library/papers/7015660PubMed
7000209Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980.Blut1980https://conductscience.org/library/papers/7000209PubMed
6992852Effect of cyclosporin A on the survival of corneal grafts in rabbits.Br J Ophthalmol1980https://conductscience.org/library/papers/6992852PubMed
6976245Inhibitory effect of cyclosporin A on peripheral blood and bone marrow T lymphocyte colony formation.Clin Exp Immunol1981https://conductscience.org/library/papers/6976245PubMed
6972916Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A.Infect Immun1981https://conductscience.org/library/papers/6972916PubMed
6807391Cyclosporin A as prophylaxis against graft-versus-host disease in 36 patients.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6807391PubMed
6797510Adult acute leukaemia: prospects for cure.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6797510PubMed
6754333Cyclosporin A. Clinical pharmacology and therapeutic potential.Drugs1982https://conductscience.org/library/papers/6754333PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/82837

GET https://conductscience.org/api/papers/v1/82837/cited_by?page=2